Velarion Records
Free. Unsubscribe any time.

Seres Therapeutics, Inc. (MCRB)

Seres Therapeutics, Inc. filed 28 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 28 transactions and 33,595 shares. 28 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 8 results prints are on file in the same window.

What stands out

Trades in Seres Therapeutics, Inc. 28

Adoption dates in Seres Therapeutics, Inc. 5

Results prints in Seres Therapeutics, Inc. 8

Trades before a print in Seres Therapeutics, Inc. 0

Interval to Seres Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Seres Therapeutics, Inc. states

Filing text: “10b5-1 instruction adopted by the reporting person on March 11, 2023”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.